These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33865921)

  • 21. Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide.
    Zheng Y; Mao YF; Zhao HJ; Chen L; Wang LN; Zhang YX; Hu J; Li JM; Li XY; Zhu HM
    Exp Hematol Oncol; 2021 Feb; 10(1):10. PubMed ID: 33549147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arsenic speciation in the blood of arsenite-treated F344 rats.
    Chen B; Lu X; Shen S; Arnold LL; Cohen SM; Le XC
    Chem Res Toxicol; 2013 Jun; 26(6):952-62. PubMed ID: 23734817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arsenic speciation in hair and nails of acute promyelocytic leukemia (APL) patients undergoing arsenic trioxide treatment.
    Chen B; Cao F; Lu X; Shen S; Zhou J; Le XC
    Talanta; 2018 Jul; 184():446-451. PubMed ID: 29674067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exceptions in patterns of arsenic compounds in urine of acute promyelocytic leukaemia patients treated with As2O3.
    Šlejkovec Z; Podgornik H; Černelč P; Falnoga I
    Biometals; 2016 Feb; 29(1):107-18. PubMed ID: 26671504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of arsenic trioxide in acute promyelocytic leukemia cells.
    Khaleghian A; Ghaffari SH; Ahmadian S; Alimoghaddam K; Ghavamzadeh A
    J Cell Biochem; 2014 Oct; 115(10):1729-39. PubMed ID: 24819152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient.
    Iriyama N; Yoshino Y; Yuan B; Horikoshi A; Hirabayashi Y; Hatta Y; Toyoda H; Takeuchi J
    J Hematol Oncol; 2012 Jan; 5():1. PubMed ID: 22272800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutathione-conjugated arsenics in the potential hepato-enteric circulation in rats.
    Suzuki KT; Tomita T; Ogra Y; Ohmichi M
    Chem Res Toxicol; 2001 Dec; 14(12):1604-11. PubMed ID: 11743743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.
    Hirano S; Kobayashi Y; Cui X; Kanno S; Hayakawa T; Shraim A
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):458-67. PubMed ID: 15276427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacokinetics of therapeutic arsenic trioxide in acute promyelocytic leukemia patients.
    Ghiuzeli CM; Stýblo M; Saunders J; Calabro A; Budman D; Allen S; Devoe C; Dhingra R
    Leuk Lymphoma; 2022 Mar; 63(3):653-663. PubMed ID: 34689693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arsenic methylation metabolism and liver injury of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
    Wang H; Xi S; Liu Z; Yang Y; Zheng Q; Wang F; Xu Y; Wang Y; Zheng Y; Sun G
    Environ Toxicol; 2013 May; 28(5):267-75. PubMed ID: 23589229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacokinetic study of arsenic trioxide in an acute promyelocytic leukemia (APL) patient: speciation of arsenic metabolites in serum and urine.
    Fukai Y; Hirata M; Ueno M; Ichikawa N; Kobayashi H; Saitoh H; Sakurai T; Kinoshita K; Kaise T; Ohta S
    Biol Pharm Bull; 2006 May; 29(5):1022-7. PubMed ID: 16651738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of arsenic metabolites in patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide.
    Zhang Z; Chen Y; Meng H; Sui M; Zhou Q; Shi C; Han L; Wang H; Zhou J
    Leuk Lymphoma; 2013 Sep; 54(9):2041-6. PubMed ID: 23343178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Speciation of arsenic trioxide penetrates into cerebrospinal fluid in patients with acute promyelocytic leukemia.
    Kiguchi T; Yoshino Y; Yuan B; Yoshizawa S; Kitahara T; Akahane D; Gotoh M; Kaise T; Toyoda H; Ohyashiki K
    Leuk Res; 2010 Mar; 34(3):403-5. PubMed ID: 19733394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue distribution of arsenic species in rabbits after single and multiple parenteral administration of arsenic trioxide: tissue accumulation and the reversibility after washout are tissue-selective.
    Lin CJ; Wu MH; Hsueh YM; Sun SS; Cheng AL
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):170-8. PubMed ID: 15322825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of combined exposure levels of total arsenic and inorganic arsenic on arsenic methylation capacity among university students: findings from Bayesian kernel machine regression analysis.
    Jiang R; Zhang Q; Ji D; Jiang T; Hu Y; He S; Tao L; Shen J; Zhang W; Song Y; Ma Y; Tong S; Tao F; Yao Y; Liang C
    Environ Sci Pollut Res Int; 2022 Apr; 29(19):28714-28724. PubMed ID: 34988804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Speciation of arsenic trioxide metabolites in blood cells and plasma of a patient with acute promyelocytic leukemia.
    Yoshino Y; Yuan B; Miyashita SI; Iriyama N; Horikoshi A; Shikino O; Toyoda H; Kaise T
    Anal Bioanal Chem; 2009 Jan; 393(2):689-97. PubMed ID: 19009285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Balance between the toxicity and anticancer activity of arsenic trioxide in treatment of acute promyelocytic leukemia.
    Wang QQ; Hua HY; Naranmandura H; Zhu HH
    Toxicol Appl Pharmacol; 2020 Dec; 409():115299. PubMed ID: 33091440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A biological indicator of inorganic arsenic exposure using the sum of urinary inorganic arsenic and monomethylarsonic acid concentrations.
    Hata A; Kurosawa H; Endo Y; Yamanaka K; Fujitani N; Endo G
    J Occup Health; 2016 May; 58(2):196-200. PubMed ID: 27010090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability study of As(III), As(V), MMA and DMA by anion exchange chromatography and HG-AFS in wastewater samples.
    Segura M; Muñoz J; Madrid Y; Cámara C
    Anal Bioanal Chem; 2002 Oct; 374(3):513-9. PubMed ID: 12373402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic Characteristics, Tissue Bioaccumulation and Toxicity Profiles of Oral Arsenic Trioxide in Rats: Implications for the Treatment and Risk Assessment of Acute Promyelocytic Leukemia.
    Liu W; Wang B; Zhao Y; Wu Z; Dong A; Chen H; Lin L; Lu J; Hai X
    Front Pharmacol; 2021; 12():647687. PubMed ID: 34122070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.